BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7457647)

  • 1. A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction.
    Marcovici M; O'Brien CP; McLellan AT; Kacian J
    Am J Psychiatry; 1981 Feb; 138(2):234-6. PubMed ID: 7457647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials.
    Glanz M; Klawansky S; McAullife W; Chalmers T
    Am J Addict; 1997; 6(4):339-49. PubMed ID: 9398932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine.
    Ling W; Rawson RA; Compton MA
    J Psychoactive Drugs; 1994; 26(2):119-28. PubMed ID: 7931856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of methadone and 1-alpha-acetylmethadol.
    Karp-Gelernter E; Wurmser L; Savage C
    Am J Psychiatry; 1976 Aug; 133(8):955-7. PubMed ID: 942010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. l-Alpha-acetylmethadol (LAAM): prognostic considerations.
    Resnick RB; Orlin L; Geyer G; Schuyten-Resnick E; Kestenbaum RS; Freedman AM
    Am J Psychiatry; 1976 Jul; 133(7):814-9. PubMed ID: 937573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAAM instead of take-home methadone.
    Resnick RB; Washton AM; Garwood J; Perzel J
    NIDA Res Monogr; 1982 Apr; 41():473-5. PubMed ID: 6811936
    [No Abstract]   [Full Text] [Related]  

  • 8. Addressing the diversion of take-home methadone: LAAM as the sole treatment choice for patients seeking maintenance therapy.
    Hough G; Washton AM; Resnick RB
    NIDA Res Monogr; 1983 Apr; 43():302-9. PubMed ID: 6410265
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).
    Tennant FS; Rawson RA; Pumphrey E; Seecof R
    J Subst Abuse Treat; 1986; 3(3):195-202. PubMed ID: 3806733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinic attendance schedules for LAAM and methadone: a controlled study.
    Karp-Gelernter E; Savage C; McCabe OL
    Int J Addict; 1982 Jul; 17(5):805-13. PubMed ID: 6752050
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical status of methadyl acetate (LAAM).
    Blaine JD; Renault PR; Thomas DB; Whysner JA
    Ann N Y Acad Sci; 1981; 362():101-15. PubMed ID: 7020527
    [No Abstract]   [Full Text] [Related]  

  • 12. A methadone/1-alpha-acetylmethadol (LAAM) maintenance study [proceedings].
    Savage C; Karp E; Curran S
    NIDA Res Monogr; 1976 Jul; (8):86-7. PubMed ID: 792706
    [No Abstract]   [Full Text] [Related]  

  • 13. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
    Stimmel B
    J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
    [No Abstract]   [Full Text] [Related]  

  • 14. Acceptability of methadyl acetate (LAAM) as compared with methadone in a treatment program for heroin addicts.
    Trueblood B; Judson BA; Goldstein A
    Drug Alcohol Depend; 1978 Mar; 3(2):125-32. PubMed ID: 631012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of LAAM and methadone utilization in an opiate agonist treatment program.
    Valdivia JF; Khattak S
    Mt Sinai J Med; 2000; 67(5-6):398-403. PubMed ID: 11064490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
    Newcombe DA; Bochner F; White JM; Somogyi AA
    Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal.
    Mendelson JH; Ellingboe J; Judson BA; Goldstein A
    Clin Pharmacol Ther; 1984 Apr; 35(4):545-7. PubMed ID: 6705455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-alpha-Acetylmethadol for treatment of chronic pain patients who abuse opioids.
    Tennant FS
    Drug Alcohol Depend; 1983 Nov; 12(3):243-7. PubMed ID: 6140153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women on LAAM maintenance: initial experiences.
    Hargreaves WA; Ling W; Brown TC; Weinberg JA; Landsberg R; Harrison WL
    J Psychedelic Drugs; 1979; 11(3):223-9. PubMed ID: 575854
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of thrice weekly LAAM and daily methadone in employed heroin addicts.
    Freedman RR; Czertko G
    Drug Alcohol Depend; 1981 Nov; 8(3):215-22. PubMed ID: 7327086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.